Portfolio
The Microbiome of Glioblastoma Multiforme and the Normal Brain: Characterization and Translational Opportunities
IN PARTNERSHIP WITH THE ISRAEL CANCER RESEARCH FUND (2022-PRESENT)
Ravid Straussman, MD, PhD, Weizmann Institute of Science, Israel
Genomic and Epidemiological Characterization of Early-Age Onset Colorectal Cancers
THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER - MARK FOUNDATION POSTDOCTORAL FELLOW (2022-PRESENT)
Wellington Oliveira dos Santos, PhD, The International Agency for Research on Cancer
NexTGen: Next Generation T Cell Therapies for Childhood Cancers
CANCER GRAND CHALLENGES AWARD, IN PARTNERSHIP WITH CANCER RESEARCH UK AND THE NATIONAL CANCER INSTITUTE (2022-Present)
Catherine Bollard, MBChB, MD, Children’s National Medical Center; Martin Pule, MD, University College London
Engineering Novel CAR T Cells for AML: Translating Lessons from Correlative Studies and Other Diseases
Damon Runyon - Mark Foundation Physician-Scientist (2022-Present)
Mark Leick, MD, Massachusetts General Hospital
Development of a Targeted Epigenome Modification Platform
Momentum Fellow (2022-present)
Anand Divakaran, PhD, University of California, Berkeley
Next Generation Organoids: Towards Understanding Cellular Crosstalk in Metastatic Cancer
Momentum Fellow (2022-present)
Anna-Marie Finger, PhD, University of California, San Francisco
Genomic Characterization of Recurrent High-Risk Neuroblastoma
Momentum Fellow (2022-present)
Kevin Ying, PhD, The Research Institute at Nationwide Children’s Hospital
Elucidating the Effects of Inflammation and Aging on Clonal Hematopoiesis
Momentum Fellow (2022-present)
Inés Fernández Maestre, PhD, Memorial Sloan Kettering Cancer Center
Investigating the Bacterial Microbiome in Brain Metastasis
ASPIRE Award (2022-Present)
Johanna Joyce, PhD, University of Lausanne and Ludwig Institute for Cancer Research Lausanne Branch (Switzerland)
